THE ROLE OF THROMBOCYTOPENIA IN POSTPARTUM HEMORRHAGE: CLINICAL IMPLICATIONS

Main Article Content

Poziljonova Dilnozakhon Uktamjon qizi

Abstract

This review highlights the role of thrombocytopenia in postpartum hemorrhage (PPH), a leading cause of maternal mortality. It explains how reduced platelet counts—caused by gestational, hypertensive, immune, or coagulation disorders—impair hemostasis and increase bleeding risk during delivery. The paper emphasizes early diagnosis, continuous platelet monitoring, and multidisciplinary management to improve maternal outcomes.

Downloads

Download data is not yet available.

Article Details

Section

Articles

How to Cite

THE ROLE OF THROMBOCYTOPENIA IN POSTPARTUM HEMORRHAGE: CLINICAL IMPLICATIONS. (2025). International Bulletin of Medical Sciences and Clinical Research, 5(10), 115-117. https://doi.org/10.37547/

References

1. Gernsheimer, T., James, A. H., & Stasi, R. (2013). How I treat thrombocytopenia in pregnancy. Blood, 121(1), 38–47.

2. Myers, B. (2012). Thrombocytopenia in pregnancy. Obstetric Medicine, 5(3), 91–96.

3. Sainio, S., Kekomäki, R., Riikonen, S., & Teramo, K. (2000). Maternal thrombocytopenia at term: a population-based study. Acta Obstetricia et Gynecologica Scandinavica, 79(9), 744–749.

4. Sibai, B. M. (2004). Diagnosis and management of gestational hypertension and preeclampsia. Obstetrics & Gynecology, 102(1), 181–192.

Similar Articles

You may also start an advanced similarity search for this article.